Trial Profile
Bioequivalence of 40 mg Telmisartan / 2.5 mg Ramipril Fixed Dose Combination Compared With the Monocomponents, Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Three-way Crossover Study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Telmisartan/ramipril (Primary) ; Ramipril; Ramipril; Telmisartan
- Indications Cardiovascular disorders; Hypertension
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 25 Aug 2014 New trial record